Multiple studies have indicated that higher ACKR1 expression levels in breast cancer tumors improve relapse-free patient survival, while loss of ACKR1 expression, frequently in patients with African ancestry, is an indicator of increased tumor aggressiveness, metastatic propensity, and mortality (156–162). This evidence concerns the gene ACKR1 and neoplasm.